Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
GenScript (Shanghai) Biotech Co., Ltd., Shanghai 200131, China.
Viruses. 2024 May 13;16(5):768. doi: 10.3390/v16050768.
Influenza vaccines, which are recommended by the World Health Organization (WHO), are the most effective preventive measure against influenza virus infection. Madin-Darby canine kidney (MDCK) cell culture is an emerging technology used to produce influenza vaccines. One challenge when purifying influenza vaccines using this cell culture system is to efficiently remove impurities, especially host cell double-stranded DNA (dsDNA) and host cell proteins (HCPs), for safety assurance. In this study, we optimized ion-exchange chromatography methods to harvest influenza viruses from an MDCK cell culture broth, the first step in influenza vaccine purification. Bind/elute was chosen as the mode of operation for simplicity. The anion-exchange Q chromatography method was able to efficiently remove dsDNA and HCPs, but the recovery rate for influenza viruses was low. However, the cation-exchange SP process was able to simultaneously achieve high dsDNA and HCP removal and high influenza virus recovery. For the SP process to work, the clarified cell culture broth needed to be diluted to reduce its ionic strength, and the optimal dilution rate was determined to be 1:2 with purified water. The SP process yielded a virus recovery rate exceeding 90%, as measured using a hemagglutination units (HAUs) assay, with removal efficiencies over 97% for HCPs and over 99% for dsDNA. Furthermore, the general applicability of the SP chromatography method was demonstrated with seven strains of influenza viruses recommended for seasonal influenza vaccine production, including H1N1, H3N2, B (Victoria), and B (Yamagata) strains, indicating that the SP process could be utilized as a platform process. The SP process developed in this study showed four advantages: (1) simple operation, (2) a high recovery rate for influenza viruses, (3) a high removal rate for major impurities, and (4) general applicability.
流感疫苗是世界卫生组织(WHO)推荐的,是预防流感病毒感染最有效的措施。犬肾传代细胞(MDCK)培养是一种新兴的技术,用于生产流感疫苗。使用这种细胞培养系统纯化流感疫苗时,面临的一个挑战是如何有效地去除杂质,特别是宿主细胞双链 DNA(dsDNA)和宿主细胞蛋白(HCP),以确保安全性。在这项研究中,我们优化了离子交换色谱方法,以从 MDCK 细胞培养物中收获流感病毒,这是流感疫苗纯化的第一步。选择结合/洗脱模式是为了操作简单。阴离子交换 Q 色谱法能够有效地去除 dsDNA 和 HCP,但流感病毒的回收率较低。然而,阳离子交换 SP 工艺能够同时实现高 dsDNA 和 HCP 去除以及高流感病毒回收率。为了使 SP 工艺发挥作用,需要将澄清的细胞培养液稀释以降低其离子强度,确定的最佳稀释率是用纯水稀释 1:2。SP 工艺的病毒回收率超过 90%,如通过血凝单位(HAU)测定法测量,HCP 的去除效率超过 97%,dsDNA 的去除效率超过 99%。此外,该 SP 色谱方法还适用于七种推荐用于季节性流感疫苗生产的流感病毒株,包括 H1N1、H3N2、B(维多利亚)和 B(Yamagata)株,表明 SP 工艺可作为平台工艺使用。本研究中开发的 SP 工艺具有四个优点:(1)操作简单,(2)流感病毒回收率高,(3)主要杂质去除率高,(4)适用性广泛。